Table 1.
Demographics of patient cohort recruited into study.
| Full cohort (n = 111) | PHB protocol (n = 52) | PHY protocol (n = 59) | p | |
|---|---|---|---|---|
| GENDER | ||||
| Female | 58 (52.3%) | 26 (50.0%) | 32 (54.2%) | 0.71 |
| Male | 53 (47.7%) | 26 (50.0%) | 27 (45.8%) | |
| PAST MEDICAL HISTORY | ||||
| HIV-infected | 3 (2.7%) | 2 (3.8%) | 1 (1.7%) | 0.60 |
| Cerebral palsy | 20 (18.0%) | 10 (19.2%) | 10 (16.9%) | 0.75 |
| Previous TBM | 3 (2.7%) | 1 (1.9%) | 1 (1.7%) | >0.99 |
| Previous TBI | 2 (1.8%) | 1 (1.9%) | 2 (3.4) | >0.99 |
| NEONATAL HISTORY | ||||
| Pre-term (< 37 weeks) | 18 (16.2%) | 7 (13.5%) | 8 (13.5%) | 0.76 |
| Documented HIE | 10 (9.0%) | 4 (7.7%) | 6 (10.2%) | 0.74 |
| SEIZURE HISTORY | ||||
| Previous admission for seizures | 51 (45.9%) | 28 (53.8%) | 23 (39.0%) | 0.13 |
| Confirmed epilepsy diagnosis | 47 (42.3%) | 26 (50.0%) | 21 (35.6%) | 0.18 |
| EPILEPSY ETIOLOGY | ||||
| Genetic | 12 (25.5%) | 7 (26.9%) | 5 (23.8%) | 0.54 |
| Infectious | 1 (2.1%) | 1 (3.8%) | – | 0.47 |
| Structural | 25 (53.2%) | 12 (46.2%) | 13 (61.9%) | >0.99 |
| Unknown | 9 (19.2%) | 6 (23.1%) | 3 (14.3%) | 0.3 |
HIE, hypoxic ischemic encephalopathy; HIV, human immune-deficiency virus; TBI, traumatic brain injury; TBM, tuberculous meningitis.